Am J Law Med. 2010;36(1):220–47.PubMed 9. United States Food and Drug Administration. FDA Talk Paper: FDA Warns Against Women Using Unapproved Drug, Domperidone, to Increase Milk Production. 2004. http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm173886.htm. Accessed July 2012. 10. United States Food and Drug Administration. Updated FDA Statement on Compounded Versions of hydroxyprogesterone caproate (the active ingredient in Makena). 2012. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm308546.htm. Accessed
July 2012. 11. Draper R. The Toxic Pharmacist. 2003. http://www.nytimes.com/2003/06/08/magazine/the-toxic-pharmacist.html?pagewanted=all&src=pm. Accessed July 2012. 12. Kastango E. Quality-control analytical methods: USP chapter 〈797〉 compounded sterile preparations sterility requirements and their relationship to beyond-use dating. Int J Pharm Selonsertib concentration Compd. 2004;8(5):393–7. 13. Pharmaceutical compounding—sterile preparations (general chapter 797). United States Repotrectinib Pharmacopeia 35—National Formulary 30. Rockville: United States YM155 Pharmacopeial Convention; 2012. 14. Sterility Tests (general chapter 71). United States Pharmacopeia 35—National Formulary 30. Rockville: United States Pharmacopeial Convention; 2012. 15. National Association of Boards of Pharmacy
Model Pharmacy Act/Rules Page 207. 2012. http://www.nabp.net/government-affairs/model-actrules/. Accessed Apr 2012. 16. Texas State Board of Pharmacy, Business Meeting Minutes, February 9–10, 2010, Proposal of Rules, Rules Concerning Use of Sterile Gloves Farnesyltransferase and Sterile Alcohol in Pharmacies Compounding Sterile Preparations (§291.133]. 2010. http://www.tsbp.state.tx.us/files_pdf/min2_2010.pdf. Accessed Nov 2012. 17. United States Food and Drug Administration. Meds IV pharmacy, IV compounded products recall: outbreak of Serratia marcescens bacteremia in Alabama hospitals. March 30,
2011. 2011. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm249099.htm. Accessed Aug 2012. 18. Tainted TPN Cases Put Focus on 〈797〉 Rules, Pharmacy Practice News, June 2011, Volume 38. 2011. http://issuu.com/mcmahongroup/docs/ppn0611_de. Accessed Nov 2012. 19. Institute for Safe Medical Practices Safety Alert. TPN-related deaths call for FDA guidance and pharmacy board oversight of USP chapter 〈797〉. 2011. http://www.ismp.org/newsletters/acutecare/articles/20110407.asp. Accessed July 2012. 20. Fricker MP, Trissel LA, Rich DS. Turning a new chapter on IV drug compounding safety: USP/NF chapter 〈797〉. Hosp Pharm. 2004;9:899–920. 21. ACOG Committee opinion no. 532: compounded bioidentical menopausal hormone therapy. Obstet Gynecol. 2012;120(2 Pt 1):411–5. 22. Newton D, Trissel L. A primer on USP chapter 〈797〉 “pharmaceutical compounding—sterile preparations”, and USP process for drug and practice standards. Int J Pharm Compd.